Investor Research

[ latest news | index A-Z | FindingHealthOnline | S&P 500 Visualization ]

A Lightning Round caller asked CNBC's Jim Cramer about Regeneron Pharmaceuticals Inc. (Jim's post).

Cramer told him that he’d rather see investors in any of his cancer-related biotech spec stocks.

We fell out of our chairs. Regeneron was a great speculative pick that day.

The very next day Regeneron skyrocketed 25% on news that the company and Sanofi-Aventis had expanded their partnership to develop a number of Regeneron's experimental drugs.

The caller apparently knew to track the news using the service we offer for free. We recommend searching our news archive to find potential winners and losers. You'll find business decisions and US FDA actions that can help predict where a company's stock is headed, like Targacept at one point up 800% over a 3 period.

21CFR Portal About My Drug Alternative Medicine Cancer Dictionary Career Finder CFR Portal Company Websites Controlled Substances Diagnosis Tool Disease Control/Prevention Drug Safety Encyclopedia (Medical) Encyclopedia (Veterinary) European Medicines Agency Federal Register FOI (Veterinary) Free Prescriptions Generic Drug Approvals Generic Drug News Health & Human Services Health Organizations Medical Encyclopedia National Institutes of Health Organizations by Symptom Pharma Address Book Pharma Careers Pharma Company Websites Pharma News Regulatory Dictionary Stocks (Pharmaceutical) Thesaurus Veterinary Encyclopedia Veterinary FOI Veterinary Medicine

Recently In the News…